GOSS
Gossamer Bio·NASDAQ
--
--(--)
--
--(--)
GOSS fundamentals
Gossamer Bio (GOSS) released its earnings on Aug 5, 2025: revenue was 11.49M (YoY -88.01%), beat estimates; EPS was -0.17 (YoY -177.27%), beat estimates.
Revenue / YoY
11.49M
-88.01%
EPS / YoY
-0.17
-177.27%
Report date
Aug 5, 2025
EPS
Actual | -0.87 | -1 | -0.8 | -0.88 | -0.78 | -0.8 | -0.8 | -0.74 | -0.76 | -0.74 | -0.65 | -0.59 | -0.52 | -0.45 | -0.21 | -0.21 | -0.19 | 0.22 | -0.14 | -0.15 | -0.16 | -0.17 | ||||
Forecast | -0.7867 | -0.8633 | -0.8533 | -0.79 | -0.756 | -0.758 | -0.785 | -0.7513 | -0.7661 | -0.691 | -0.6428 | -0.623 | -0.53 | -0.4892 | -0.2565 | -0.2083 | -0.1901 | 0.5067 | -0.1472 | -0.17 | -0.1871 | -0.1771 | ||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -10.59% | -15.83% | +6.25% | -11.39% | -3.17% | -5.54% | -1.91% | +1.50% | +0.80% | -7.09% | -1.12% | +5.30% | +1.89% | +8.01% | +18.13% | -0.82% | +0.05% | -56.58% | +4.89% | +11.76% | +14.48% | +4.01% |
Revenue
Actual | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 95.84M | 9.48M | 9.38M | 9.89M | 11.49M |
Forecast | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 114.29M | 8.53M | 6.83M | 4.07M | 5.41M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -16.14% | +11.14% | +37.24% | +143.13% | +112.41% |
Earnings Call
You can ask Aime
What is Gossamer Bio's latest dividend and current dividend yield?Did Gossamer Bio beat or miss consensus estimates last quarter?What factors drove the changes in Gossamer Bio's revenue and profit?What is Gossamer Bio's gross profit margin?What is the revenue and EPS growth rate for Gossamer Bio year over year?What guidance did Gossamer Bio's management provide for the next earnings period?What is the market's earnings forecast for Gossamer Bio next quarter?What were the key takeaways from Gossamer Bio’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
